Pieris Pharma a Strong Stock in Emerging Biotech

An alternative investment portfolio could benefit from forward-thinking pharmaceutical stocks. While Pieris Pharmaceuticals Inc. (NASDAQ: PIRS) doesn’t engage in the popular cannabis market, it does have promising biotechnologies that could shape some aspects of healthcare in the future. Pieris develops and discovers drugs based on anticalin proteins. These artificial proteins mimic the body’s natural antibodies […]